Caricamento...
Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?
Standard pharmacological therapy in Takotsubo syndrome (TTS) is still debated and there is a lack of prospective data. In their recent work in BMC Cardiovascular Disorders Abanador-Kamper et al. found that stroke in TTS has an event rate of 2.8% after 30 days and 4.2% after 12 months and they questi...
Salvato in:
| Pubblicato in: | BMC Cardiovasc Disord |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206855/ https://ncbi.nlm.nih.gov/pubmed/30373518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0930-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|